Market revenue in 2023 | USD 1.5 million |
Market revenue in 2030 | USD 2.6 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Anti-bacterial |
Fastest growing segment | Corticosteroids |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-bacterial, Anti-fungal, Corticosteroids, Others (Acaricidals, Cyclosporins) |
Key market players worldwide | Zoetis, Elanco Animal Health Inc, Dechra Pharmaceuticals, Merck & Co Inc, Vetoquinol SA, Virbac SA, CEVA Inc, Penn Veterinary Supply Inc, Vedco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal ear infection treatment market will help companies and investors design strategic landscapes.
Anti-bacterial was the largest segment with a revenue share of 46.67% in 2023. Horizon Databook has segmented the Saudi Arabia companion animal ear infection treatment market based on anti-bacterial, anti-fungal, corticosteroids, others (acaricidals, cyclosporins) covering the revenue growth of each sub-segment from 2018 to 2030.
The Saudi Arabia market is driven by the local presence and undertakings of notable players, including their launch of products, collaborations & acquisitions, and partnerships. For instance, in November 2021, Merck & Co., Inc. acquired Acceleron Pharma, Inc. Post this acquisition, the company expanded its cardiovascular portfolio and enhanced its business development strategies.
In February 2021, MSD Animal Health, also known as Merck Animal Health in North America, acquired Poultry Sense Ltd., a poultry health and environmental monitoring solutions provider. The company’s portfolio was merged into Merck Animal Health Intelligence’s operating unit.
In August 2020, Merck Animal Health acquired worldwide rights to the VECOXAN brand of parasiticides from Elanco Animal Health. This acquisition added the brand to the company’s Ruminant product offerings.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia companion animal ear infection treatment market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia companion animal ear infection treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account